Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells. DiScala M, Najor MS, Yung T, Morgan D, et al. PLoS One 2020;15:e0234146.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

DiScala M, Najor MS, Yung T, Morgan D, et al. Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells. PLoS One 2020;15:e0234146.
PMID: 32525891